WADA commends introduction of NBA hGH Blood Testing

WADA Director General, David Howman: “By agreeing to testing for human growth hormone (hGH), the NBA and NBPA will improve the effectiveness of their anti-doping program and enhance its value in terms of deterrence.”
WADA commends the measures taken by the National Basketball Association (NBA) and the National Basketball Players Association (NBPA) in introducing human growth hormone (hGH) blood testing for players at the start of the 2015-2016 season.
By agreeing to testing for human growth hormone (hGH), the NBA and NBPA will improve the effectiveness of their anti-doping program and enhance its value in terms of deterrence.
We look forward to seeing similar advances in the wider NBA anti-doping program, and continuing our discussions with the NBA on their anti-doping program in the future.